Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00128557 |
Recruitment Status
:
Terminated
(Study terminated based on DSMB recommendation in December 2006)
First Posted
: August 10, 2005
Last Update Posted
: April 10, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Infant Mortality Vitamin A Deficiency | Drug: vitamin A supplementation (50,000 IU) | Phase 3 |
Study Type : | Interventional |
Enrollment : | 25000 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double |
Primary Purpose: | Prevention |
Official Title: | A Randomized Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh |
Study Start Date : | January 2004 |
Actual Study Completion Date : | December 2006 |

- 24-week infant mortality rate

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 30 Days (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Infants born to women enrolled in a maternal supplementation trial, alive and less than 30 days of age during a newborn dosing visit

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00128557
Bangladesh | |
JiVitA Bangladesh Project | |
Rangpur, Rajshahi Division, Bangladesh |
Principal Investigator: | Rolf DW Klemm, Dr PH | Johns Hopkins University | |
Study Director: | Keith P West, Jr., Dr. P.H. | Johns Hopkins Bloomberg School of Public Health | |
Study Director: | Parul Christian, Dr. P.H. | Johns Hopkins Bloomberg School of Public Health | |
Study Director: | Mahbubar Rashid, MBBS, MSc, MBA | JiVitA Bangladesh Project | |
Study Director: | Alain B. Labrique, MSc | Johns Hopkins Bloomberg School of Public Health | |
Study Director: | Alfred Sommer, M.D. | Johns Hopkins Bloomberg School of Public Health |
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00128557 History of Changes |
Other Study ID Numbers: |
H.22.03.01.09.A2 |
First Posted: | August 10, 2005 Key Record Dates |
Last Update Posted: | April 10, 2007 |
Last Verified: | April 2007 |
Keywords provided by Johns Hopkins Bloomberg School of Public Health:
Vitamin A Newborn health Infant Mortality |
Supplementation Micronutrients Bangladesh |
Additional relevant MeSH terms:
Vitamin A Deficiency Vitamin A Retinol palmitate Night Blindness Infant Death Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Vision Disorders Eye Diseases |
Death Pathologic Processes Vitamins Micronutrients Growth Substances Physiological Effects of Drugs Antioxidants Molecular Mechanisms of Pharmacological Action Protective Agents Anticarcinogenic Agents Antineoplastic Agents |